Release Date: 31/01/13 19:12 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 1.07MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%